A Critical Shortage

A mother from Preston is calling for urgent government action as her 17-year-old son, Ben, faces a life-threatening interruption to his medical cannabis treatment. Ben, who suffers from severe, drug-resistant epilepsy, has seen a 90% reduction in seizures over the last seven years while using Bedrolite and Bedica oils.

However, the Dutch pharmacy responsible for dispensing these prescriptions, Bedrocan, is set to close on 1 December following bankruptcy. With only five weeks of medication remaining, the family is warning that the loss of this treatment could be fatal.

Call for Government Intervention

Ben’s mother, Joanne, who is a director of the campaign group End Our Pain, has criticised the UK government's slow response. While the Dutch government has engaged in talks regarding the temporary export of plant material to allow a UK manufacturer to step in, families report a lack of urgency from Westminster.

"My son is going to die," Joanne told the BBC during a demonstration at Parliament. "We need access as soon as possible."

Official Response

A spokesperson for the Department of Health and Social Care stated: "We have been working intensively on this issue in recent weeks... We believe there to be sufficient stock to maintain supplies in the coming months while a long-term solution is found."

Despite these assurances, the case highlights the ongoing fragility of the UK’s medical cannabis framework, which has struggled to provide consistent, reliable access for patients since legalisation in 2018.

Source: Yahoo News